Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial fibrosis, the silent instigator of diastolic dysfunction in patients with rheumatoid arthritis.

Physiological research·2025
Same author

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.

Journal of endocrinological investigation·2024
Same author

Parathyroid Hormone-Related Changes of Bone Structure.

Physiological research·2022
Same author

Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study.

Physiological research·2022
Same author

Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis.

Physiological research·2022
Same author

The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up.

Physiological research·2022
Same journal

Rheumatology at the Threshold of Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Murine Hind Limb Explant Model for Studying the Mechanobiology of Achilles Tendon Impingement
08:19

Murine Hind Limb Explant Model for Studying the Mechanobiology of Achilles Tendon Impingement

Published on: December 8, 2023

Arthropathy in acromegaly.

Z Killinger1, J Payer, I Lazúrová

  • 1Fifth Internal Clinic, University Hospital, Ružinovská 6, 826 06 Bratislava, Slovakia.

Rheumatic Diseases Clinics of North America
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

Acromegaly frequently causes joint problems, which can be the first sign. Early diagnosis and treatment of acromegaly are crucial to prevent complications and improve patient quality of life.

More Related Videos

Application of Acupotomy in a Knee Osteoarthritis Model in Rabbit
08:40

Application of Acupotomy in a Knee Osteoarthritis Model in Rabbit

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jun 6, 2026

Murine Hind Limb Explant Model for Studying the Mechanobiology of Achilles Tendon Impingement
08:19

Murine Hind Limb Explant Model for Studying the Mechanobiology of Achilles Tendon Impingement

Published on: December 8, 2023

Application of Acupotomy in a Knee Osteoarthritis Model in Rabbit
08:40

Application of Acupotomy in a Knee Osteoarthritis Model in Rabbit

Published on: October 20, 2023

Area of Science:

  • Endocrinology
  • Rheumatology
  • Internal Medicine

Background:

  • Acromegaly, a disorder caused by excess growth hormone, commonly presents with articular involvement.
  • Joint complications are a frequent and often early clinical manifestation in acromegaly patients.
  • Systemic organ involvement in acromegaly significantly impacts patient morbidity and mortality.

Purpose of the Study:

  • To highlight the clinical significance of articular and systemic organ involvement in acromegaly.
  • To emphasize the importance of early diagnosis and timely intervention for acromegaly.
  • To underscore the potential for preventing irreversible complications and enhancing patient quality of life.

Main Methods:

  • Review of clinical manifestations in acromegaly patients.
  • Analysis of the impact of articular and organ involvement on disease progression.
  • Evaluation of treatment strategies for managing acromegaly and its complications.

Main Results:

  • Articular involvement is a highly prevalent complication of acromegaly.
  • Early symptoms of acromegaly can be predominantly articular.
  • Systemic organ involvement contributes significantly to the overall morbidity and mortality associated with acromegaly.

Conclusions:

  • Prompt diagnosis and appropriate management of acromegaly are essential.
  • Intervention can prevent the development of irreversible complications.
  • Effective treatment improves the quality of life for individuals with acromegaly.